Status:
COMPLETED
Early Palliative Care Intervention in Malignant Glioma
Lead Sponsor:
Duke University
Collaborating Sponsors:
Duke Cancer Institute
Conditions:
Malignant Glioma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research study is to determine the feasibility and acceptability of incorporating palliative care into the clinical care plans of patients newly diagnosed with malignant brain tumo...
Detailed Description
Patients who agree to participate at their initial consultation in our clinic will receive a referral to a Palliative Care (PC) provider who is also located in our clinic and an initial appointment wi...
Eligibility Criteria
Inclusion
- ≥ 18 years of age
- Patient must have histologically confirmed, newly diagnosed WHO grade IV malignant glioma (confirmation from biopsy, sub-total, or gross-total resection)
- Tumor must be de novo grade IV malignant glioma (i.e. NOT transformed from a lower grade)
- Patient should be planning to receive standard chemoradiation (3 or 6 week protocols are acceptable)
- Treating neuro-oncologist agrees to the patient's participation in this clinical trial
- Patient should be able to read and write English
Exclusion
- Patient who currently has a PC provider and/or is receiving hospice care or plans on initiating hospice at the time of enrollment
Key Trial Info
Start Date :
May 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 17 2019
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03471546
Start Date
May 16 2018
End Date
June 17 2019
Last Update
November 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Preston Robert Tisch Brain Tumor Center
Durham, North Carolina, United States, 27710